2 unchanged sentences
Incorporated by reference herein
−Removed: 2020 Equity Incentive Plan and related forms of agreement
−Removed: August 5, 2020
−Removed: Letter Relating to Employment Terms – Susan G.
−Removed: Kim effective as of September 28, 2020
−Removed: Filed herewith
−Removed: Change in Control and Severance Agreement by and between the Company and Susan G.
−Removed: Kim effective as of September 28, 2020
−Removed: Filed herewith
+Added: Indenture, dated February 16, 2021, between Pacific Biosciences of California, Inc.
+Added: Bank National Association, as Trustee
+Added: February 17, 2021
+Added: Form of 1.50% Convertible Senior Notes due 2028 (included in Exhibit 4.1)
+Added: February 17, 2021
+Added: Investment Agreement, dated as of February 9, 2021, between Pacific Biosciences of California, Inc.
+Added: and SB Northstar LP
+Added: February 10, 2021
+Added: Form of Change in Control and Severance Agreement for executive officers
+Added: February 26, 2021
+Added: Amended Change in Control and Severance Agreement by and between the Registrant and Christian O.
+Added: Henry dated February 3, 2021
+Added: February 26, 2021
+Added: Letter Relating to Employment Terms by and between the Registrant and Mark Van Oene effective January 8, 2021
+Added: February 26, 2021
+Added: Letter Relating to Employment Terms by and between the Registrant and Peter Fromen effective January 8, 2021
+Added: February 26, 2021
+Added: Pacific Biosciences of California, Inc.
+Added: 2020 Inducement Equity Incentive Plan, as amended, and forms of agreement thereunder
+Added: April 19, 2021
+Added: Development and Commercialization Agreement by and between the Registrant and Invitae Corporation dated January 12, 2021
+Added: February 26, 2021
Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
16 unchanged sentences
+ Indicates management contract or compensatory plan
+Added: † Certain confidential information contained in this Exhibit was omitted by means of marking such portions with brackets because the identified confidential information (i) is not material and (ii) would be competitively harmful if publicly disclosed.
* The certifications attached as Exhibit 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Pacific Biosciences of California, Inc.
2 unchanged sentences
P ACIFIC B IOSCIENCES OF C ALIFORNIA , I NC .
−Removed: November 2, 2020
/s/ S USAN G.
Chief Financial Officer
−Removed: November 2, 2020
Vice President and Chief Accounting Officer
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.